Pediatric Exclusivity Would Be Reduced To Three Months Under Bipartisan Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
The Lower PRICED Drugs Act from Sens. Lott (R-Miss.) and Stabenow (D-Mich.) also proposes to expand generic competition to non-“Orange Book”-listed antibiotics and to revise how 30-month stays are applied.